UAE Crescent Enterprises’ CE-Ventures invests in London startup Oyster Therapeutics
Detailed summary
UAE-based Crescent Enterprises’ CE-Ventures has invested in London-based biotech firm Oyster Therapeutics, formerly Kesmalea Therapeutics. Create a free ZAWYA account to access…
UAE-based Crescent Enterprises’ CE-Ventures has invested in London-based biotech firm Oyster Therapeutics, formerly Kesmalea Therapeutics.
Create a free ZAWYA account to access exclusive financial news, analysis, and insights.
Disclaimer: This article is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Read our full disclaimer policy here.
Opening of the article, excerpted from Zawya. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.zawya.com)
